Revvity Q4 revenue falls 6% to $696 million; initiates 2024 guidance
Revvity reported fourth-quarter 2023 revenue of $696 million, down from $741 million a year earlier, and adjusted EPS from continuing operations of $1.25, down from $1.41. For full year 2023, adjusted EPS fell to $4.65 from $6.92 and revenue fell to $2,751 million from $3,313 million, and the company initiated 2024 guidance of $2.79-$2.85 billion in revenue and $4.55-$4.75 in adjusted EPS.
Key points
- Q4 2023 revenue was $696 million, down 6% on a reported basis from $741 million; GAAP EPS was $0.64 versus $1.01.
- Full year 2023 adjusted EPS from continuing operations was $4.65, versus $6.92 in 2022; Diagnostics full-year revenue fell 28% to $1,459 million.
- 2024 guidance: total revenue of $2.79-$2.85 billion and adjusted EPS of $4.55-$4.75.
- Full year 2023 GAAP EPS of $5.55 was boosted by income from discontinued operations of $4.11 per share.
The filing
Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 01, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.